BlackRock Advisors’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

BlackRock Advisors’s Portfolio STAB Stock Details STAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$4K	Hold	2,800	–	–	﹤0.01%	3649
2016 Q3	$5K	Hold	2,800	–	–	﹤0.01%	3645
2016 Q2	$8K	Hold	2,800	–	–	﹤0.01%	3622
2016 Q1	$7K	Hold	2,800	–	–	﹤0.01%	3634
2015 Q4	$10K	Hold	2,800	–	–	﹤0.01%	3629
2015 Q3	$12K	Hold	2,800	–	–	﹤0.01%	3627
2015 Q2	$12K	Buy	2,800 +1,759	+169%	+$5.3K	﹤0.01%	3594
2015 Q1	$4K	Hold	1,041	–	–	﹤0.01%	3573
2014 Q4	$6K	Hold	1,041	–	–	﹤0.01%	3637
2014 Q3	$10K	Hold	1,041	–	–	﹤0.01%	3583
2014 Q2	$10K	Hold	1,041	–	–	﹤0.01%	3575
2014 Q1	$14K	Hold	1,041	–	–	﹤0.01%	3494
2013 Q4	$24K	Buy	1,041 +479	+85%	+$13K	﹤0.01%	3361
2013 Q3	$18K	Buy	562 +6	+1%	+$198	﹤0.01%	3339
2013 Q2	$18K	Buy	+556	New	+$19.1K	﹤0.01%	3292

Other funds holding STAB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock Advisors's STAB Position: Q4 2016 in Review

BlackRock Advisors held its Statera Biopharma, Inc. Common Stock (STAB) position steady in Q4 2016 at 2,800 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #3649.

BlackRock Advisors first reported a position in STAB in Q2 2013 and has held it in 15 quarters since. The position peaked at $24K in Q4 2013. 20 funds tracked by Wall St. Rank hold STAB as of Q4 2016.

BlackRock Advisors held 2,800 shares of Statera Biopharma, Inc. Common Stock worth $4K as of Q4 2016.
BlackRock Advisors left its Statera Biopharma, Inc. Common Stock share count unchanged in Q4 2016.
Statera Biopharma, Inc. Common Stock made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3649 holding.
BlackRock Advisors first reported a position in Statera Biopharma, Inc. Common Stock in Q2 2013 and has held it in 15 quarters since.
BlackRock Advisors's Statera Biopharma, Inc. Common Stock position peaked at $24K in Q4 2013.
20 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.